News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC
Hidehito Horinouchi/X
Mar 29, 2025, 12:57

Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC

Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared a post on X:

“Now out.

COCOON: Preventing Moderate to Severe Dermatologic Adverse Events in First-line EGFR-mutant Advanced NSCLC Treated with Amivantamab Plus Lazertinib.

Presented by Nicolas Girard.

AEs ≥G2: OR 0.19 (95% CI, 0.09–0.40)

NCT06120140.”

Read further.

Hidehito Horinouchi: COCOON trial on preventing dermatologic adverse events in EGFR-mutant NSCLC

More posts featuring Hidehito Horinouchi.

cancer COCOON EGFR-mutant Advanced NSCLC ELCC25 Hidehito Horinouchi NSCLC OncoDaily Oncology
Special Coverage
Blog
May 10, 2025, 19:04
Elizabeth Ugwoma Awo-Ejeh: Mental stress is something we hardly talk about, yet it's something almost everyone carries
Insight
May 10, 2025, 18:11
Digestive Cancers Europe highlights Sara Ben Hmido’s study on patient perspectives of AI in surgical decision-making
Blog
May 10, 2025, 18:03
April Dorenbosch discussed migrant struggles with cancer care in Europe in Youth Cancer Europe interview
Insight
May 10, 2025, 17:56
David Planchard discussed EGFR-mutated NSCLC and clinical research developments with chinese colleagues
Blog
May 10, 2025, 17:48
Manette Le Grange Highlights ACT for Children Initiative in Pediatric Cancer Care
Blog
May 10, 2025, 17:44
Ashish Shah Explores Viral Mimicry Approach to Glioblastoma at Sylvester Comprehensive Cancer Center
Societies
May 10, 2025, 17:43
LUNGevity Foundation: Upal Basu Roy on progress in Small Cell Lung Cancer research
Science
May 10, 2025, 17:34
Galip Can Uyar: Prediction of 90-day Mortality Among Cancer Patients with Unplanned Hospitalisation
Insight
May 10, 2025, 17:23
Roupen Odabashian reflects on 2025 JAMA study evaluating AI-generated discharge summaries
Drugs
May 10, 2025, 17:11
A*STAR IMCB study led by Valerie Yang identified AZD5153 and Pazopanib drug combination for soft tissue sarcoma treatment
Blog
May 10, 2025, 17:10
Nnamdi Igwe Receives Barry Coller Award for Excellence in Clinical Medicine - Mount Sinai Department of Medicine
Drugs
May 10, 2025, 17:01
FDA approved Bristol Myers Squibb’s Opdivo + Yervoy for first-line treatment of MSI-H/dMMR metastatic colorectal cancer